MapLight Therapeutics, Inc. Expense Breakdown
No Expense Breakdown for MPLT on this site yet.
- 2026-06-30: Clinical Trial $20.72M; Employee Related $16.84M; Preclinical Program $8.29M; Chemistry, manufacturing and controls expenses $6.33M.
- 2025-06-30: Clinical Trial $5.99M; Employee Related $6.96M; Preclinical Program $9.73M; Chemistry, manufacturing and controls expenses $3.40M.
Source checked: the stored Expense Breakdown page for MPLT.
Expenses by product
Research and development: each quarter (3 month)
| Quarter end | Clinical Trial | Employee Related | Preclinical Program | Chemistry, manufacturing and controls expenses | Other Operating |
|---|
| 2026-06-30 | $20.72M | $16.84M | $8.29M | $6.33M | $1.26M |
|---|
| 2025-06-30 | $5.99M | $6.96M | $9.73M | $3.40M | $770.00K |
|---|
General and Administrative Expense: each quarter (3 month)
| Quarter end | Employee Related | Professional Fees |
|---|
| 2026-06-30 | $5.77M | $4.34M |
|---|
| 2025-06-30 | $1.90M | $1.92M |
|---|